ATE321773T1 - Semisynthetisches verfahren zur herstellung von didemninanalogen - Google Patents

Semisynthetisches verfahren zur herstellung von didemninanalogen

Info

Publication number
ATE321773T1
ATE321773T1 AT97911896T AT97911896T ATE321773T1 AT E321773 T1 ATE321773 T1 AT E321773T1 AT 97911896 T AT97911896 T AT 97911896T AT 97911896 T AT97911896 T AT 97911896T AT E321773 T1 ATE321773 T1 AT E321773T1
Authority
AT
Austria
Prior art keywords
didemnine
analogues
producing
semisynthetic process
semisynthetic
Prior art date
Application number
AT97911896T
Other languages
English (en)
Inventor
Kenneth L Rinehart
Alexandra J Sanborn
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Application granted granted Critical
Publication of ATE321773T1 publication Critical patent/ATE321773T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT97911896T 1996-10-24 1997-10-24 Semisynthetisches verfahren zur herstellung von didemninanalogen ATE321773T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2911296P 1996-10-24 1996-10-24

Publications (1)

Publication Number Publication Date
ATE321773T1 true ATE321773T1 (de) 2006-04-15

Family

ID=21847298

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97911896T ATE321773T1 (de) 1996-10-24 1997-10-24 Semisynthetisches verfahren zur herstellung von didemninanalogen

Country Status (9)

Country Link
US (1) US6841530B2 (de)
EP (1) EP0973518B1 (de)
JP (1) JP2001503746A (de)
AT (1) ATE321773T1 (de)
AU (1) AU731757B2 (de)
CA (1) CA2269881A1 (de)
DE (1) DE69735583T2 (de)
ES (1) ES2262175T3 (de)
WO (1) WO1998017275A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030148933A1 (en) 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
ES2272462T3 (es) 2000-04-07 2007-05-01 The Trustees Of The University Of Pennsylvania Analogos de tamadarina y didemnina y procedimiento de fabricacion y uso.
US6509315B1 (en) 2000-04-07 2003-01-21 The Trustees Of The University Of Pennsylvania Didemnin analogs and fragments and methods of making and using them
GB0103750D0 (en) * 2001-02-15 2001-04-04 Pharma Mar Sa Synthetic methods for aplidine and new antitumoral derivatives methods of making and using them
UA76718C2 (uk) 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
GB0016148D0 (en) * 2000-06-30 2000-08-23 Pharma Mar Sa Synthetic methods for aplidine and new antitiumoral derivatives
BR0114604A (pt) 2000-10-12 2003-10-14 Pharma Mar Sa Tratamento de c‰nceres
KR20060002778A (ko) 2003-03-12 2006-01-09 파르마 마르, 에스.에이. 개선된 항종양 치료
JP4584245B2 (ja) 2003-03-12 2010-11-17 ダナ−ファーバー キャンサー インスティテュート,インコーポレイテッド 多発性骨髄腫治療用のアプリジン
AU2004224418A1 (en) 2003-03-21 2004-10-07 Madeleine M. Joullie Tamandarin analogs and fragments thereof and methods of making and using
HUE028055T2 (en) 2006-02-28 2016-11-28 Pharma Mar Sa Improved treatment of myeloma multiplex
WO2013041969A2 (en) 2011-09-21 2013-03-28 King Abdullah University Of Science And Technology Didemnin biosynthetic gene cluster in tistrella mobilis
LT3615544T (lt) 2017-04-27 2023-05-10 Pharma Mar S.A. Priešnavikiniai junginiai
CN115594739B (zh) * 2021-06-28 2025-02-14 浙江珲达生物科技有限公司 一种dehydrodidemnin B类化合物的制备方法
CN116284222A (zh) * 2021-12-14 2023-06-23 浙江珲达生物科技有限公司 一种Didemnin B的分离纯化方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950649A (en) * 1980-09-12 1990-08-21 University Of Illinois Didemnins and nordidemnins
US4493796A (en) * 1980-09-12 1985-01-15 Board Of Trustees, Univ. Of Ill. Didemnins A, B, C, and derivatives thereof, as antiviral agents
US4948791A (en) * 1989-04-10 1990-08-14 The Board Of Trustees Of The University Of Illinois Novel Cytotoxic cyclic depsipeptides from the tunicate trididemnum solidum

Also Published As

Publication number Publication date
DE69735583T2 (de) 2007-04-05
EP0973518B1 (de) 2006-03-29
WO1998017275A1 (en) 1998-04-30
EP0973518A1 (de) 2000-01-26
DE69735583D1 (de) 2006-05-18
AU731757B2 (en) 2001-04-05
US6841530B2 (en) 2005-01-11
JP2001503746A (ja) 2001-03-21
US20020037835A1 (en) 2002-03-28
AU4916597A (en) 1998-05-15
CA2269881A1 (en) 1998-04-30
ES2262175T3 (es) 2006-11-16
EP0973518A4 (de) 2004-05-26

Similar Documents

Publication Publication Date Title
DE69020175D1 (de) Verfahren zur Herstellung von Organosiliciumverbindungen.
DE69012535D1 (de) Verfahren zur Herstellung von Hydrogensiloxanen.
DE69735583D1 (de) Semisynthetisches verfahren zur herstellung von didemninanalogen
DE3784123D1 (de) Verfahren zur herstellung keramischer verbundwerkstoffe.
DE19781729T1 (de) Verfahren zur Herstellung von Monoestern von 1,3-Diolen
DE69013710D1 (de) Verfahren zur Herstellung von Organosiliciumverbindungen.
DE69113695D1 (de) Verfahren zur Herstellung von Perfluoralkoxysulfonverbindungen.
DE69707215D1 (de) Verfahren zur Herstellung von Perfluoropolyethern
DE59005420D1 (de) Verfahren zur Herstellung von Dialkylcarbonaten.
DE69009614D1 (de) Verfahren zur Herstellung von (S)-gamma-Hydroxymethyl-alpha,beta-Butenolid.
DE59104845D1 (de) Verfahren zur Herstellung von 2-Chlor-5-methyl-pyridin.
DE59004274D1 (de) Verfahren zur Herstellung von Alkylhalogensilanen.
DE69020830D1 (de) Verfahren zur Herstellung von (S)-4-Hydroxymethyl-gamma-lacton.
DE68911571D1 (de) Verfahren zur Herstellung von Silikonschaum-Zusammensetzungen.
DE69313556D1 (de) Verfahren zur Herstellung von zyklischen Depsipeptiden
DE59105577D1 (de) Verfahren zur Herstellung von Arylcarbonaten.
DE59300777D1 (de) Verfahren zur Herstellung von Perfluorpolyethern.
DE69006864D1 (de) Verfahren zur Herstellung von Organosiliciumverbindungen.
DE59407675D1 (de) Verfahren zur Herstellung von 6H-Dibenz-(c,e)(1,2)-oxaphosphorin-6-on
DE68912809D1 (de) Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin.
DE59101444D1 (de) Verfahren zur Herstellung von p-Amino-phenolen.
DE69006820D1 (de) Verfahren zur Herstellung von 1,1-Dichlorotetrafluorethan.
DE69109510D1 (de) Verfahren zur Herstellung von Glycin.
DE59105908D1 (de) Verfahren zur Herstellung von Bis(hydroxymethyl)phosphinaten.
DE69010526D1 (de) Verfahren zur Herstellung von L-Alanin.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties